Today: 7 February 2026
Subscribe
Browse Category

Earnings Reports News 5 February 2026

Analog Devices stock pops as chip dealmaking back in focus ahead of ADI earnings

Analog Devices stock pops as chip dealmaking back in focus ahead of ADI earnings

Analog Devices shares rose 3% to $320.44 Wednesday, bucking declines in major chip stocks. The move followed Texas Instruments’ $7.5 billion deal to buy Silicon Labs, drawing attention to the analog chip sector. Trading volume in ADI topped its recent average. Investors are focused on ADI’s Feb. 18 earnings for signals on demand and margins.
5 February 2026
···
Amgen stock jumps 8% after earnings beat — what to know before Thursday’s open

Amgen stock jumps 8% after earnings beat — what to know before Thursday’s open

Amgen shares surged 8.2% to $366.20 Wednesday after quarterly earnings beat forecasts and the company issued a 2026 outlook above consensus. Investors focused on progress in Amgen’s MariTide obesity program, which could allow less frequent dosing. The company reported Q4 revenue of $9.9 billion and adjusted EPS of $5.29. Amgen plans $2.6 billion in 2026 capital spending and capped share buybacks at $3 billion.
5 February 2026
···
Coca-Cola stock steadies after CEO Quincey’s sale filing as Wall Street braces for Feb. 10 results

Coca-Cola stock steadies after CEO Quincey’s sale filing as Wall Street braces for Feb. 10 results

Coca-Cola closed up 0.6% at $77.35 on Wednesday, steadying after hours as an SEC filing showed CEO James Quincey plans to sell about 337,824 shares worth $25.4 million. Jefferies raised its price target to $88 ahead of next week’s earnings. UBS cited expectations for another “on-algorithm” year. The planned sale represents less than 0.01% of Coke’s outstanding shares.
5 February 2026
··
PayPal stock price slips after-hours as CEO shake-up and weak 2026 outlook keep PYPL under pressure

PayPal stock price slips after-hours as CEO shake-up and weak 2026 outlook keep PYPL under pressure

PayPal shares fell 1.6% to $41.03 in after-hours trading Wednesday after the company named HP’s Enrique Lores as CEO, replacing Alex Chriss. The stock drop followed weak 2026 profit guidance and a slowdown in branded checkout growth. PayPal reported Q4 revenue of $8.68 billion and adjusted EPS of $1.23, but scrapped its 2027 targets. CFO Jamie Miller will serve as interim CEO until March 1.
5 February 2026
·
Bloom Energy stock slides in after-hours as traders brace for Thursday earnings

Bloom Energy stock slides in after-hours as traders brace for Thursday earnings

Bloom Energy shares dropped 12.8% to $147.35 in after-hours trading Wednesday after a volatile session. Wall Street expects fourth-quarter profits to fall from last year despite higher revenue, with analysts forecasting $0.25 per share on $649.12 million in sales. Investors are focused on guidance and orders tied to data-center power demand. Bloom reports earnings Thursday after the close.
5 February 2026
···
Merck stock rises after-hours as cautious 2026 forecast meets new cholesterol pill headlines

Merck stock rises after-hours as cautious 2026 forecast meets new cholesterol pill headlines

Merck shares rose 2.2% to $118.33 in after-hours trading Wednesday after new data showed its experimental cholesterol drug enlicitide cut LDL by up to 60% in a major trial. The company’s 2026 revenue forecast of $65.5–$67.0 billion missed Wall Street estimates, citing pressure from off-patent drugs and U.S. pricing. Keytruda sales reached $8.37 billion last quarter, while Gardasil revenue fell 34%.
5 February 2026
···
Booking (BKNG) stock slips after-hours as AI worries hit analyst notes ahead of Feb. 18 results

Booking (BKNG) stock slips after-hours as AI worries hit analyst notes ahead of Feb. 18 results

Booking Holdings shares fell 0.8% to $4,607.13 in after-hours trading Wednesday after Citizens Bank downgraded the stock, citing AI risks and a lack of near-term growth drivers. The stock has dropped 9.3% since Tuesday amid heavy volume and sector-wide declines. Booking will report fourth-quarter and full-year earnings on Feb. 18. KeyBanc maintained an overweight rating but trimmed its price target.
5 February 2026
··
Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

Coinbase stock slides after Nevada lawsuit over sports event contracts; earnings ahead

Coinbase shares fell 6.2% to $168.62 in after-hours trading Wednesday after Nevada’s gaming regulator filed a civil enforcement action to block the company’s sports-linked event contracts. The Nevada Gaming Control Board seeks a court order halting what it calls unlicensed wagering. Coinbase called the move a “state power grab,” arguing federal law should apply. Bitcoin and ether also dropped, weighing on exchange stocks.
5 February 2026
···
S&P Global stock tries to find a floor after AI scare rout; Mobility Global spin-off and earnings loom

S&P Global stock tries to find a floor after AI scare rout; Mobility Global spin-off and earnings loom

S&P Global shares fell 0.6% to $465.51 Wednesday, extending a two-day drop to nearly 12% amid concerns over AI’s impact on data firms. Trading volume was four times the 20-day average. The company’s Mobility division will rebrand as Mobility Global ahead of a planned spin-off, pending board approval. S&P Global reports earnings Feb. 10.
5 February 2026
···
Cisco stock falls after hours as tech selloff bites; CSCO earnings loom next week

Cisco stock falls after hours as tech selloff bites; CSCO earnings loom next week

Cisco shares fell 2.3% to $81.16 in after-hours trading Wednesday, following a broader tech sell-off that pushed the Nasdaq down 1.51%. The company will report fiscal Q2 earnings on Feb. 11 and recently announced NBC Sports will use its AI networking tech for the 2026 Winter Olympics. Cisco also launched an AI-powered security tool and promoted its AI strategy at a summit with Nvidia.
5 February 2026
··
AbbVie stock slides after earnings: Rinvoq miss dents ABBV despite upbeat 2026 view

AbbVie stock slides after earnings: Rinvoq miss dents ABBV despite upbeat 2026 view

AbbVie shares fell 3.9% in after-hours trading Wednesday after quarterly results showed Rinvoq sales missed expectations at $2.37 billion. Skyrizi sales beat forecasts at $5.01 billion, while Humira revenue dropped 25.9% to $1.25 billion. The company projected 2026 adjusted earnings above estimates, but investors focused on challenges replacing Humira as biosimilar competition grows.
5 February 2026
···
IREN stock plunges 17% as bitcoin slides again, setting up a tense earnings read

IREN stock plunges 17% as bitcoin slides again, setting up a tense earnings read

IREN shares fell 17.4% to $44.94 in heavy after-hours trading Wednesday, tracking a 3.3% drop in bitcoin. Volume reached 66.2 million shares. A Jane Street filing disclosed a 4.7% stake in IREN days ahead of its earnings report, due after the bell Thursday. Other U.S.-listed bitcoin miners also declined.
5 February 2026
········
Applied Materials stock hammered after-hours as chip selloff deepens — what to watch next

Applied Materials stock hammered after-hours as chip selloff deepens — what to watch next

Applied Materials shares fell 6.6% to $297.60 in after-hours trading Wednesday as chip equipment stocks slid and investors braced for next week’s earnings report. The PHLX semiconductor index dropped 4.4%, while Lam Research fell 8.8% and KLA lost 3.6%. The Nasdaq closed down 1.51%. Traders are watching Applied’s Feb. 12 results for signals on chip demand and sector stability.
5 February 2026
······
1 … 8 9 10 11 12 … 202

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop